메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국기업법학회 기업법연구 기업법연구 제20권 제1호
발행연도
2006.3
수록면
123 - 147 (25page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
During the takeover wave of the 1980s, managers developed numerous strategies to fend off unwanted bidders and retain control of their firms in America. These strategies included the poison pill, often used in combination with the effective classified board.
The universal type of poison pill in America is flip-in/flip-over right plan. This plan is to endow “the rights” to common shareholders with the type of dividends excepting bidders. It is to be introduced by one-side behaviour of the board of directors of issuing corporation, because the dividends to shareholders is made by only decision of the board of directors.
But corporate scholars expressed concern over the serious conflict of interest inherent in managerial control over takeovers, arising from the fact that takeovers often presage managerial termination. Many corporate scholars argued that the poison pill should be prohibited. Many also concluded that managers should be required to submit bids to shareholders. Recently, the proposals to secure effective participation of shareholders in poison pill is gaining persuasive powers considerably.
To introduce American poison pill, the wide discretion to the board of directors must be endowed, the kinds of dividends must be diversified and the principle of the equal treatment of shareholders must be amended with the principle of one-share one-voting right through the amendment of commercial Law and Securities Law. And to introduce American poison pill, the diverse defensive tactics against Hostile M&A must be examined together.

목차

Ⅰ. 서론
Ⅱ. 종래의 동향
Ⅲ. 최근의 새로운 동향
Ⅳ. 결론
참고문헌
〈Abstract〉

참고문헌 (17)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2009-366-015562009